Stay updated on Seagen Press Releases

Sign up to get notified when there's something new on the Seagen Press Releases page.
Latest website image capture
Clouds background image

Latest updates to the Seagen Press Releases page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    New press releases and category labels were added (including 12.17.2025 PADCEV+Keytruda and 12.18.2025 Finance) and older corporate entries were removed.
    Difference
    3%
    Check dated 2025-12-23T21:56:30.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    New items include Pfizer Reaffirms Full-Year 2025 EPS Guidance and Provides Full-Year 2026 Guidance (12.16.2025), Pfizer Declares First-Quarter 2026 Dividend (12.12.2025), and TUKYSA maintenance therapy update (12.10.2025). Older items related to Metsera litigation and acquisition were removed (10.31–10.30.2025).
    Difference
    8%
    Check dated 2025-12-16T21:09:50.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The page adds two new press releases on 12.06.2025 (HYMPAVZI) and 12.09.2025 (Pfizer Enters into Exclusive Collaboration and License Agreement with YaoPharma) under Prescription Medicines, Research, and Corporate. It also removes two older October 2025 items (Pfizer’s BRAFTOVI + MEKTOVI and XTANDI + Leuprolide) from the listing.
    Difference
    3%
    Check dated 2025-12-09T19:07:57.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The press releases page adds a Finance category and lists a new release about Pfizer's December 16 conference call for 2026 guidance. It also removes the October 18, 2025 PADCEV™ plus KEYTRUDA™ bladder cancer release from the listings.
    Difference
    2%
    Check dated 2025-12-02T16:41:39.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    Added: Prescription Medicines press release 'U.S. FDA Approves PADCEV® plus Keytruda® for Certain Patients with Bladder Cancer' (11.21.2025). Removed: The 'TUKYSA Combination Significantly Improves Progression-Free Survival as First-Line Maintenance in HER2+ Metastatic Breast Cancer in HER2CLIMB-05 Trial' press release (10.14.2025) under Research and Pipeline, and the United States tag.
    Difference
    2%
    Check dated 2025-11-25T11:25:08.000Z thumbnail image
  7. Check
    48 days ago
    Change Detected
    Summary
    Two new press releases were added: 'Pfizer Completes Acquisition of Metsera' (11.13.2025) and 'Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference' (11.12.2025) under Corporate and Research and Pipeline. Two older items were removed: 'Pfizer Declares Fourth-Quarter 2025 Dividend' (10.09.2025) and 'Pfizer to Highlight Advancements in Respiratory Health and Infectious Disease Research at IDWeek 2025' (10.13.2025).
    Difference
    3%
    Check dated 2025-11-18T07:11:41.000Z thumbnail image

Stay in the know with updates to Seagen Press Releases

Enter your email address, and we'll notify you when there's something new on the Seagen Press Releases page.